TMPyP4 tosylate
CAS No. 36951-72-1
TMPyP4 tosylate( TMP 1363 )
Catalog No. M26486 CAS No. 36951-72-1
TMPyP4 tosylate is a quadruplex-specific ligand and is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 42 | In Stock |
|
| 50MG | 61 | In Stock |
|
| 100MG | 87 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTMPyP4 tosylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTMPyP4 tosylate is a quadruplex-specific ligand and is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines.
-
DescriptionTMPyP4 tosylate is a quadruplex-specific ligand and is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines.
-
In VitroCell Viability Assay Cell Line:HOS cells Concentration:50? μM Incubation Time:48 or 96 h Result:Time-dependently inhibited cell viability.Western Blot Analysis Cell Line:K562 cells Concentration:100? μM Incubation Time:24 or 48 h Result:Increased the expression of p21CIP1 protein and p57KIP2 protein.
-
In VivoAnimal Model:MX-1 mammary chemoadjuvant model Dosage:10 and 20 mg/kg Administration:Intraperitoneal injection (i.p.), twice weekly.Result:Inhibited tumor growth and prolonged mice survival.Animal Model:SARS-CoV-2-infected hamster Dosage:15?mg/kg or 30?mg/kg Administration:i.n., starting at 1?h prior to virus inoculation and continuing until 3 days post infection Result:Decreased the mean viral loads in the nasal wash, nasal turbinate and lung tissues.
-
SynonymsTMP 1363
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorVHL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36951-72-1
-
Formula Weight1363.6
-
Molecular FormulaC72H66N8O12S4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (7.33 mM助)
-
SMILESCc1ccc(cc1)S([O-])(=O)=O.Cc1ccc(cc1)S([O-])(=O)=O.Cc1ccc(cc1)S([O-])(=O)=O.Cc1ccc(cc1)S([O-])(=O)=O.C[n+]1ccc(cc1)-c1c2ccc(n2)c(-c2cc[n+](C)cc2)c2ccc([nH]2)c(-c2cc[n+](C)cc2)c2ccc(n2)c(-c2cc[n+](C)cc2)c2ccc1[nH]2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
CCG-203971
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
-
Vitamin D2
Vitamin D2 has a strong inhibitory effect against bladder tumor promotion by sodium saccharin and induces cell differentiation in leukemia cells.
-
ZM 39923 hydrochlori...
ZM 39923 hydrochloride is a JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activity to JAK2 and modestly potent to EGFR; also found to be sensitive to transglutaminase.
Cart
sales@molnova.com